NCT01724385View on ClinicalTrials.gov

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Vitreous HemorrhageProliferative Diabetic Retinopathy
Interventions
DRUG

intravitreal injection of bevacizumab

intravitreal injection of bevacizumab

Trial Locations (1)

40002

Srinagarind Hospital, Khon Kaen University, Khon Kaen

All Listed Sponsors
lead

Khon Kaen University

OTHER

NCT01724385 - Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter